| Group (n) . | Sporadic Alzheimer's disease set1/controls . | Sporadic Alzheimer's disease set2/FTLD . | Sporadic Alzheimer's disease set3/controls . | |||
|---|---|---|---|---|---|---|
| . | Alzheimer's disease (20) . | Controls (20) . | Alzheimer's disease (18) . | FTLD (19) . | Alzheimer's disease (14) . | Controls (14) . |
| Sex (F/M) | 11/9 | 10/10 | 6/12 | 8/11 | 5/9 | 5/9 |
| Age (mean, range) at MRI-scan | 81.0 (51–102) | 79.5 (55–91) | 66.0 (53–85) | 61.7 (46–73) | 65.0 (53–85) | 63.0 (51–81) |
| MMSE-score (mean, range) | 16.7 (7–29) | 29.0 (27–30) | 16.2a (5–29) | 18.0 (0–26) | 16.1a (10–20) | 29.2 (28–30) |
| Years from MRI-scan to death (mean, range) | 1.7 (0.2–3.4) | NA | 3.5 (0.3–7.2) | 5.8 (1.3–11.0) | 3.6 (0.3–7.2) | NA |
| Group (n) . | Sporadic Alzheimer's disease set1/controls . | Sporadic Alzheimer's disease set2/FTLD . | Sporadic Alzheimer's disease set3/controls . | |||
|---|---|---|---|---|---|---|
| . | Alzheimer's disease (20) . | Controls (20) . | Alzheimer's disease (18) . | FTLD (19) . | Alzheimer's disease (14) . | Controls (14) . |
| Sex (F/M) | 11/9 | 10/10 | 6/12 | 8/11 | 5/9 | 5/9 |
| Age (mean, range) at MRI-scan | 81.0 (51–102) | 79.5 (55–91) | 66.0 (53–85) | 61.7 (46–73) | 65.0 (53–85) | 63.0 (51–81) |
| MMSE-score (mean, range) | 16.7 (7–29) | 29.0 (27–30) | 16.2a (5–29) | 18.0 (0–26) | 16.1a (10–20) | 29.2 (28–30) |
| Years from MRI-scan to death (mean, range) | 1.7 (0.2–3.4) | NA | 3.5 (0.3–7.2) | 5.8 (1.3–11.0) | 3.6 (0.3–7.2) | NA |
aMMSE scores obtained around the time of scanning only available from 12 subjects.
| Group (n) . | Sporadic Alzheimer's disease set1/controls . | Sporadic Alzheimer's disease set2/FTLD . | Sporadic Alzheimer's disease set3/controls . | |||
|---|---|---|---|---|---|---|
| . | Alzheimer's disease (20) . | Controls (20) . | Alzheimer's disease (18) . | FTLD (19) . | Alzheimer's disease (14) . | Controls (14) . |
| Sex (F/M) | 11/9 | 10/10 | 6/12 | 8/11 | 5/9 | 5/9 |
| Age (mean, range) at MRI-scan | 81.0 (51–102) | 79.5 (55–91) | 66.0 (53–85) | 61.7 (46–73) | 65.0 (53–85) | 63.0 (51–81) |
| MMSE-score (mean, range) | 16.7 (7–29) | 29.0 (27–30) | 16.2a (5–29) | 18.0 (0–26) | 16.1a (10–20) | 29.2 (28–30) |
| Years from MRI-scan to death (mean, range) | 1.7 (0.2–3.4) | NA | 3.5 (0.3–7.2) | 5.8 (1.3–11.0) | 3.6 (0.3–7.2) | NA |
| Group (n) . | Sporadic Alzheimer's disease set1/controls . | Sporadic Alzheimer's disease set2/FTLD . | Sporadic Alzheimer's disease set3/controls . | |||
|---|---|---|---|---|---|---|
| . | Alzheimer's disease (20) . | Controls (20) . | Alzheimer's disease (18) . | FTLD (19) . | Alzheimer's disease (14) . | Controls (14) . |
| Sex (F/M) | 11/9 | 10/10 | 6/12 | 8/11 | 5/9 | 5/9 |
| Age (mean, range) at MRI-scan | 81.0 (51–102) | 79.5 (55–91) | 66.0 (53–85) | 61.7 (46–73) | 65.0 (53–85) | 63.0 (51–81) |
| MMSE-score (mean, range) | 16.7 (7–29) | 29.0 (27–30) | 16.2a (5–29) | 18.0 (0–26) | 16.1a (10–20) | 29.2 (28–30) |
| Years from MRI-scan to death (mean, range) | 1.7 (0.2–3.4) | NA | 3.5 (0.3–7.2) | 5.8 (1.3–11.0) | 3.6 (0.3–7.2) | NA |
aMMSE scores obtained around the time of scanning only available from 12 subjects.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
